Inhibition of RNA polymerase I transcription initiation by CX-5461 activates non-canonical ATM/ATR signaling

RNA polymerase I (Pol I)-mediated transcription of the ribosomal RNA genes (rDNA) is confined to the nucleolus and is a rate-limiting step for cell growth and proliferation. Inhibition of Pol I by CX-5461 can selectively induce p53-mediated apoptosis of tumour cells in vivo. Currently, CX-5461 is in clinical trial for patients with advanced haematological malignancies (Peter Mac, Melbourne). Here we demonstrate that CX-5461 also induces p53-independent cell cycle checkpoints mediated by ATM/ATR signaling in the absence of DNA damage. Further, our data demonstrate that the combination of drugs targeting ATM/ATR signaling and CX-5461 leads to enhanced therapeutic benefit in treating p53-null tumours in vivo, which are normally refractory to each drug alone. Mechanistically, we show that CX-5461 induces an unusual chromatin structure in which transcriptionally competent relaxed rDNA repeats are devoid of transcribing Pol I leading to activation of ATM signaling within the nucleoli. Thus, we propose that acute inhibition of Pol transcription initiation by CX-5461 induces a novel nucleolar stress response that can be targeted to improve therapeutic efficacy.

• Publication year

  2016

• Venue

  OncoTarget

• Publication date

  2016-07-06

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.18632/oncotarget.10452PMID 27391441PMCID 5226549
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Combination Therapy Targeting Ribosome Biogenesis and mRNA Translation Synergistically Extends Survival in MYC-Driven Lymphoma.

  2016cited by this paper
• rRNA synthesis inhibitor, CX-5461, activates ATM/ATR pathway in acute lymphoblastic leukemia, arrests cells in G2 phase and induces apoptosis

  2015cited by this paper
• Nucleolar responses to DNA double-strand breaks

  2015cited by this paper
• The nucleolus as a fundamental regulator of the p53 response and a new target for cancer therapy.

  2015cited by this paper
• ATM and ATR as therapeutic targets in cancer.

  2015cited by this paper
• A novel role for the Pol I transcription factor UBTF in maintaining genome stability through the regulation of highly transcribed Pol II genes

  2015cited by this paper
• Transient rRNA synthesis inhibition with CX-5461 is sufficient to elicit growth arrest and cell death in acute lymphoblastic leukemia cells

  2015cited by this paper
• The core spliceosome as target and effector of non-canonical ATM signaling

  2015cited by this paper
• Constitutive activation of the DNA damage response pathway as a novel therapeutic target in diffuse large B-cell lymphoma

  2015cited by this paper
• Not All DDRs Are Created Equal: Non-Canonical DNA Damage Responses.

  2015cited by this paper
• A localized nucleolar DNA damage response facilitates recruitment of the homology-directed repair machinery independent of cell cycle stage

  2015influential reference
• Targeting the nucleolus for cancer-specific activation of p53.

  2014cited by this paper
• Activation of DNA damage response signaling by condensed chromatin.

  2014cited by this paper
• ATR Mediates a Checkpoint at the Nuclear Envelope in Response to Mechanical Stress

  2014cited by this paper
• R: A language and environment for statistical computing.

  2014cited by this paper
• Activation of the tumor suppressor p53 upon impairment of ribosome biogenesis.

  2014cited by this paper
• Targeting the nucleolus for cancer intervention.

  2014cited by this paper
• Ribosomal proteins as unrevealed caretakers for cellular stress and genomic instability

  2014cited by this paper
• HTSeq—a Python framework to work with high-throughput sequencing data

  2014cited by this paper
• Connecting the nucleolus to the cell cycle and human disease

  2014cited by this paper
• Perturbations at the ribosomal genes loci are at the centre of cellular dysfunction and human disease

  2014cited by this paper
• Targeting RNA polymerase I to treat MYC-driven cancer

  2014cited by this paper
• The nucleolus: an emerging target for cancer therapy.

  2013cited by this paper
• Detection of G-quadruplex DNA in mammalian cells

  2013cited by this paper
• KAT5 tyrosine phosphorylation couples chromatin sensing to ATM signalling

  2013cited by this paper
• The Arf/p53 Protein Module, Which Induces Apoptosis, Down-regulates Histone H2AX to Allow Normal Cells to Survive in the Presence of Anti-cancer Drugs*

  2013cited by this paper
• Old Drug, New Target

  2013cited by this paper
• Targeting RNA polymerase I transcription and the nucleolus for cancer therapy

  2013cited by this paper
• Combined inhibition of PI3K-related DNA damage response kinases and mTORC1 induces apoptosis in MYC-driven B-cell lymphomas.

  2013cited by this paper
• Nucleolar control of p53: a cellular Achilles’ heel and a target for cancer therapy

  2013cited by this paper
• Functional ribosome biogenesis is a prerequisite for p53 destabilization: impact of chemotherapy on nucleolar functions and RNA metabolism

  2013cited by this paper
• Dysregulation of the basal RNA polymerase transcription apparatus in cancer

  2013cited by this paper
• Suprainduction of p53 by disruption of 40S and 60S ribosome biogenesis leads to the activation of a novel G2/M checkpoint.

  2012cited by this paper
• Efficacy of CHK inhibitors as single agents in MYC-driven lymphoma cells

  2012cited by this paper
• Inhibition of RNA polymerase I as a therapeutic strategy to promote cancer-specific activation of p53.

  2012cited by this paper
• [Visualizing spatiotemporal dynamics of multicellular cell-cycle progression].

  2012cited by this paper
• Dynamics of DNA damage response proteins at DNA breaks: a focus on protein modifications.

  2011cited by this paper
• The nucleolus.

  2011cited by this paper
• Targeting RNA polymerase I with an oral small molecule CX-5461 inhibits ribosomal RNA synthesis and solid tumor growth.

  2011cited by this paper
• The nucleus introduced.

  2011cited by this paper
• Integrating diverse genomic data using gene sets

  2011cited by this paper
• Differential expression analysis for sequence count data

  2010cited by this paper
• The Nucleolus under Stress

  2010cited by this paper
• Ribosome biogenesis surveillance: probing the ribosomal protein-Mdm2-p53 pathway

  2010cited by this paper
• The ATM-Chk2 and ATR-Chk1 pathways in DNA damage signaling and cancer.

  2010cited by this paper
• The senescence-associated secretory phenotype: the dark side of tumor suppression.

  2010influential reference
• ATM activation in the presence of oxidative stress

  2010cited by this paper
• Anticancer activity of CX-3543: a direct inhibitor of rRNA biogenesis.

  2009cited by this paper
• Signaling to p53: ribosomal proteins find their way.

  2009influential reference
• Searching for SNPs with cloud computing

  2009cited by this paper
• The role of UBF in regulating the structure and dynamics of transcriptionally active rDNA chromatin

  2009cited by this paper
• Ultrafast and memory-efficient alignment of short DNA sequences to the human genome

  2009cited by this paper
• Stabilization of quadruplex DNA perturbs telomere replication leading to the activation of an ATR-dependent ATM signaling pathway

  2009cited by this paper
• Activation of the Cellular DNA Damage Response in the Absence of DNA Lesions

  2008cited by this paper
• UBF levels determine the number of active ribosomal RNA genes in mammals

  2008cited by this paper
• NOPdb: Nucleolar Proteome Database—2008 update

  2008cited by this paper
• ATM Activation and Signaling under Hypoxic Conditions

  2008cited by this paper
• Visualizing spatiotemporal dynamics of multicellular cell-cycle progression.

  2008cited by this paper
• The multifunctional nucleolus

  2007cited by this paper
• Nucleolus: the fascinating nuclear body

  2007cited by this paper
• Hyperthermia activates a subset of ataxia-telangiectasia mutated effectors independent of DNA strand breaks and heat shock protein 70 status.

  2007cited by this paper
• Recognizing and exploiting differences between RNAi and small-molecule inhibitors.

  2007cited by this paper
• BMC Evolutionary Biology BioMed Central Research article The architecture of mammalian ribosomal protein promoters

  2005cited by this paper
• Nucleolar proteome dynamics

  2005cited by this paper
• Key role of the achievement of an appropriate ribosomal RNA complement for G1‐S phase transition in H4‐II‐E‐C3 rat hepatoma cells

  2005cited by this paper
• Dynamic sorting of nuclear components into distinct nucleolar caps during transcriptional inhibition.

  2005influential reference
• Inactivation of S6 ribosomal protein gene in T lymphocytes activates a p53-dependent checkpoint response.

  2005cited by this paper
• Sensing Cellular Stress: Another New Function for the Nucleolus?

  2004cited by this paper
• DNA damage and repair measured in different genomic regions using the comet assay with fluorescent in situ hybridization.

  2004influential reference
• Essential role of ribosomal protein L11 in mediating growth inhibition‐induced p53 activation

  2004cited by this paper
• Ribosomal Protein L23 Activates p53 by Inhibiting MDM2 Function in Response to Ribosomal Perturbation but Not to Translation Inhibition

  2004cited by this paper
• Regulation of HDM2 activity by the ribosomal protein L11.

  2003cited by this paper
• In Exponentially Growing Saccharomyces cerevisiae Cells, rRNA Synthesis Is Determined by the Summed RNA Polymerase I Loading Rate Rather than by the Number of Active Genes

  2003cited by this paper
• DNA damage activates ATM through intermolecular autophosphorylation and dimer dissociation

  2003cited by this paper
• Disruption of the nucleolus mediates stabilization of p53 in response to DNA damage and other stresses

  2003cited by this paper
• A System for Stable Expression of Short Interfering RNAs in Mammalian Cells

  2002influential reference
• hRRN3 is essential in the SL1‐mediated recruitment of RNA Polymerase I to rRNA gene promoters

  2001cited by this paper
• Evidence of p53-Dependent Cross-Talk between Ribosome Biogenesis and the Cell Cycle: Effects of Nucleolar Protein Bop1 on G1/S Transition

  2001cited by this paper
• ATM phosphorylates p95/nbs1 in an S-phase checkpoint pathway

  2000cited by this paper
• P53 Regulates Myogenesis by Triggering the Differentiation Activity of Prb

  2000cited by this paper
• ATM associates with and phosphorylates p53: mapping the region of interaction

  1999cited by this paper
• p53 Negatively Regulates cdc2 Transcription via the CCAAT-binding NF-Y Transcription Factor*

  1999cited by this paper
• A role for ATR in the DNA damage-induced phosphorylation of p53.

  1999cited by this paper
• Creation of human tumour cells with defined genetic elements

  1999cited by this paper
• Activation of the ATM kinase by ionizing radiation and phosphorylation of p53.

  1998cited by this paper
• Enhanced phosphorylation of p53 by ATM in response to DNA damage.

  1998cited by this paper
• Characterization of I-Ppo, an intron-encoded endonuclease that mediates homing of a group I intron in the ribosomal DNA of Physarum polycephalum

  1990cited by this paper

• Nucleolus, Nucleolar Stress and Cardiovascular Diseases

  2026cites this paper
• Nucleolus as a cornerstone linking proliferation and metabolism to cellular responses to stress: involvement of transcription factors MYC and p53.

  2026cites this paper
• The G-quadruplex ligand CX-5461: an innovative candidate for disease treatment

  2025cites this paper
• Ribosome Biogenesis and Function in Cancer: From Mechanisms to Therapy

  2025cites this paper
• Gestational age-based outcomes of neonates with Down syndrome in the neonatal intensive care unit (NICU): review of pediatric health information system (PHIS) database

  2025cites this paper
• Ubiquitination of Oncogenic Mutant p53 via Attenuation of Ribosome Biogenesis Machinery Effectively Inhibits Pancreatic Tumor Growth

  2025cites this paper
• Nucleolar origins: challenging perspectives on evolution and function

  2025cites this paper
• NPM1 mislocalization mediated by RNA Pol I inhibition alters chromatin landscape

  2025cites this paper
• Dual RNA Polymerase I Inhibition with CX-5461 and BMH-21 Synergizes in Breast Cancer by Activating p53-Dependent Stress

  2025cites this paper
• Targeting RNA polymerase I to boost natural killer cell anticancer activity in multiple myeloma

  2025cites this paper
• Novel RNA Polymerase I and Cyclin Dependent Kinase combination therapy for the treatment of aggressive Acute Myeloid Leukemia

  2025cites this paper
• The natural alkaloid nitidine chloride targets RNA polymerase I to inhibit ribosome biogenesis and repress cancer cell growth

  2025cites this paper
• Reducing the metabolic burden of rRNA synthesis promotes healthy longevity in Caenorhabditis elegans

  2024cites this paper
• Molecular basis of CX-5461-induced DNA damage response in primary vascular smooth muscle cells

  2024cites this paper
• CX-5461 Preferentially Induces Top2α-Dependent DNA Breaks at Ribosomal DNA Loci

  2024influential citation
• Polymerase I as a Target for Treating Neurodegenerative Disorders

  2024cites this paper
• Ribosome subunit attrition and activation of the p53-MDM4 axis dominate the response of MLL-rearranged cancer cells to WDR5 WIN site inhibition.

  2024cites this paper
• Targeting the ribosome to treat multiple myeloma

  2024cites this paper
• CX‑5461 potentiates imatinib‑induced apoptosis in K562 cells by stimulating KIF1B expression

  2024cites this paper
• Boosting regulatory T cell-dependent immune tolerance by activation of p53.

  2023cites this paper
• HMG-boxes, ribosomopathies and neurodegenerative disease

  2023cites this paper
• Ribosome subunit attrition and activation of the p53–MDM4 axis dominate the response of MLL-rearranged cancer cells to WDR5 WIN site inhibition

  2023cites this paper
• Small Molecule RBI2 Disrupts Ribosome Biogenesis through Pre-rRNA Depletion

  2023cites this paper
• Inhibition of nucleolar transcription by oxaliplatin involves ATM/ATR kinase signaling.

  2023cites this paper
• CX-5461-inspired monofunctional platinum RNA polymerase I selective inhibitors with selective lethality in BRCA1-deficient cancer cells

  2023cites this paper
• PAF49: An RNA Polymerase I subunit essential for rDNA transcription and stabilization of PAF53

  2023cites this paper
• Targeting RNA Polymerase I Transcription Activity in Osteosarcoma: Pre-Clinical Molecular and Animal Treatment Studies

  2023cites this paper
• An ERK1/2‐driven RNA‐binding switch in nucleolin drives ribosome biogenesis and pancreatic tumorigenesis downstream of RAS oncogene

  2023cites this paper
• Targeting Mutant Dicer Tumorigenesis in Pleuropulmonary Blastoma via Inhibition of RNA Polymerase I.

  2023cites this paper
• Ribosome Biogenesis: A Central Player in Cancer Metastasis and Therapeutic Resistance

  2022cites this paper
• Repression of T cell-mediated alloimmunity by CX-5461 via the p53-DUSP5 pathway.

  2022cites this paper
• CX-5461 induces radiosensitization through modification of the DNA damage response and not inhibition of RNA polymerase I

  2022cites this paper
• CX-5461 induces radiosensitization through modification of the DNA damage response and not inhibition of RNA polymerase I

  2022cites this paper
• A G-quadruplex stabilizer, CX-5461 combined with two immune checkpoint inhibitors enhances in vivo therapeutic efficacy by increasing PD-L1 expression in colorectal cancer

  2022cites this paper
• A transcriptional program associated with cell cycle regulation predominates in the anti-inflammatory effects of CX-5461 in macrophage

  2022influential citation
• DMPC/Chol liposomal copper CX5461 is therapeutically superior to a DSPC/Chol formulation.

  2022cites this paper
• CX-5461 causes nucleolar compaction, alteration of peri- and intranucleolar chromatin arrangement, an increase in both heterochromatin and DNA damage response

  2022cites this paper
• Targeting Ribosome Biogenesis in Cancer: Lessons Learned and Way Forward

  2022cites this paper
• The therapeutic potential of RNA Polymerase I transcription inhibitor, CX-5461, in uterine leiomyosarcoma

  2022cites this paper
• The p53 pathway in vasculature revisited: a therapeutic target for pathological vascular remodeling?

  2021cites this paper
• Ubiquitin-mediated DNA damage response is synthetic lethal with G-quadruplex stabilizer CX-5461

  2021cites this paper
• Therapeutic efficacy of the novel selective RNA polymerase I inhibitor CX‐5461 on pulmonary arterial hypertension and associated vascular remodelling

  2021cites this paper
• Impaired ribosome biogenesis checkpoint activation induces p53-dependent MCL-1 degradation and MYC-driven lymphoma death.

  2021cites this paper
• Identification of a ten-long noncoding RNA signature for predicting the survival and immune status of patients with bladder urothelial carcinoma based on the GEO database: a superior machine learning model

  2021cites this paper
• An RNA-binding switch drives ribosome biogenesis and tumorigenesis downstream of RAS oncogene

  2021cites this paper
• Ribosomal proteins and human diseases: molecular mechanisms and targeted therapy

  2021cites this paper
• Harnessing the Nucleolar DNA Damage Response in Cancer Therapy

  2021cites this paper
• CX-5461 Sensitizes DNA Damage Repair–proficient Castrate-resistant Prostate Cancer to PARP Inhibition

  2021cites this paper
• Targeting BRF2 in Cancer Using Repurposed Drugs

  2021cites this paper
• Anti-fibrotic effects of p53 activation induced by RNA polymerase I inhibitor in primary cardiac fibroblasts.

  2021cites this paper
• Ribosomal RNA Transcription Regulation in Breast Cancer

  2021cites this paper
• CX-5461 Enhances the Efficacy of APR-246 via Induction of DNA Damage and Replication Stress in Triple-Negative Breast Cancer

  2021cites this paper
• Sequence-dependent inhibition of cGAS and TLR9 DNA sensing by 2′-O-methyl gapmer oligonucleotides

  2021cites this paper
• Targeting BRF2 in Cancer with Repurposed Drugs Using in Silico Methods

  2020cites this paper
• Targeting the RNA Polymerase I Transcription for Cancer Therapy Comes of Age

  2020cites this paper
• PGRMC1 phosphorylation affects cell shape, motility, glycolysis, mitochondrial form and function, and tumor growth

  2020cites this paper
• rDNA Chromatin Activity Status as a Biomarker of Sensitivity to the RNA Polymerase I Transcription Inhibitor CX-5461

  2020cites this paper
• A tiered female ovarian toxicity screening identifies toxic effects of checkpoint kinase 1 inhibitors on murine growing follicles.

  2020cites this paper
• Dysregulated Ribosome Biogenesis Reveals Therapeutic Liabilities in Cancer.

  2020cites this paper
• EBP2, a novel NPM‐ALK‐interacting protein in the nucleolus, contributes to the proliferation of ALCL cells by regulating tumor suppressor p53

  2020cites this paper
• Transcriptional suppression of ribosomal DNA with phase separation

  2020cites this paper
• CX-5461 can destabilize replication forks in PARP inhibitor-resistant models of ovarian cancer

  2020cites this paper
• Nucleolar stress induces a senescence-like phenotype in smooth muscle cells and promotes development of vascular degeneration

  2020cites this paper
• The RNA polymerase I transcription inhibitor CX-5461 cooperates with topoisomerase 1 inhibition by enhancing the DNA damage response in homologous recombination-proficient high-grade serous ovarian cancer

  2020cites this paper
• The chemotherapeutic agent CX-5461 irreversibly blocks RNA polymerase I initiation and promoter release to cause nucleolar disruption, DNA damage and cell inviability

  2020cites this paper
• CX-5461 activates the DNA damage response and demonstrates therapeutic efficacy in high-grade serous ovarian cancer

  2020cites this paper
• PGRMC1 phosphorylation and cell plasticity 1: glycolysis, mitochondria, tumor growth

  2019cites this paper
• Targeting RNA Polymerase I transcription synergises with TOP1 inhibition in potentiating the DNA damage response in high-grade serous ovarian cancer

  2019cites this paper
• The Targeting of RNA Polymerase I Transcription Using CX-5461 in Combination with Radiation Enhances Tumour Cell Killing Effects in Human Solid Cancers

  2019cites this paper
• Ubiquitin-mediated Regulation of RNA Polymerase I in Saccharomyces cerevisiae

  2019cites this paper
• PGRMC1 phosphorylation status and cell plasticity 1: glucose metabolism, mitochondria, and mouse xenograft tumorigenesis

  2019cites this paper
• Coordinated Control of rRNA Processing by RNA Polymerase I.

  2019cites this paper
• Discovery of novel inhibitors of ribosome biogenesis by innovative high throughput screening strategies.

  2019cites this paper
• The antimalarial drug amodiaquine stabilizes p53 through ribosome biogenesis stress, independently of its autophagy-inhibitory activity

  2019cites this paper
• Various Nucleolar Stress Inducers Result in Highly Distinct Changes in Water, Dry Mass and Elemental Content in Cancerous Cell Compartments: Investigation Using a Nano-Analytical Approach

  2019influential citation
• Abnormal Ribosome Biogenesis Partly Induced p53-Dependent Aortic Medial Smooth Muscle Cell Apoptosis and Oxidative Stress

  2019cites this paper
• First-in-Human RNA Polymerase I Transcription Inhibitor CX-5461 in Patients with Advanced Hematological Cancers: Results of a Phase I Dose Escalation Study.

  2019cites this paper
• Inhibition of RNA Polymerase I Transcription Activates Targeted DNA Damage Response and Enhances the Efficacy of PARP Inhibitors in High-Grade Serous Ovarian Cancer

  2019influential citation
• Ribosome biogenesis during cell cycle arrest fuels EMT in development and disease

  2019cites this paper
• Loss of Peter Pan protein is associated with cell cycle defects and apoptotic events.

  2019cites this paper
• Changes in long-range rDNA-genomic interactions associate with altered RNA polymerase II gene programs during malignant transformation

  2019cites this paper
• Inhibition of nucleolar stress response by Sirt1: A potential mechanism of acetylation‐independent regulation of p53 accumulation

  2019cites this paper
• Inhibitors of ribosome biogenesis repress the growth of MYCN-amplified neuroblastoma

  2018cites this paper
• Patient-derived Models of Abiraterone- and Enzalutamide-resistant Prostate Cancer Reveal Sensitivity to Ribosome-directed Therapy.

  2018cites this paper
• A Nucleolar Stress–Specific p53–miR-101 Molecular Circuit Functions as an Intrinsic Tumor-Suppressor Network

  2018cites this paper
• Treating hematological malignancies with drugs inhibiting ribosome biogenesis: when and why

  2018cites this paper
• Impact of RNA polymerase I inhibitor CX‐5461 on viral kinase‐dependent and ‐independent cytomegalovirus replication

  2018cites this paper
• Transition Metal Ions Promote the Bioavailability of Hydrophobic Therapeutics: Cu and Zn Interactions with RNA Polymerase I Inhibitor CX5461.

  2018cites this paper
• Ribosomal biogenesis as an emerging target of neurodevelopmental pathologies

  2018cites this paper
• The nucleolus, an ally, and an enemy of cancer cells

  2018cites this paper
• Alternative splicing of human telomerase reverse transcriptase in gliomas and its modulation mediated by CX-5461

  2018cites this paper
• Relative roles of UBF and RRN3 in the transcription of the ribosomal RNA genes and ribosome biogenesis determined using in vivo mouse models

  2017cites this paper
• New roles for Dicer in the nucleolus and its relevance to cancer

  2017cites this paper
• Cell cycle and growth stimuli regulate different steps of RNA polymerase I transcription.

  2017cites this paper
• Inhibition of Pol I transcription treats murine and human AML by targeting the leukemia-initiating cell population.

  2017cites this paper
• Meeting report for Odd Pols 2016: Ann Arbor 2.0.

  2017influential citation
• Inhibition of Pol I Transcription a New Chance in the Fight Against Cancer

  2017cites this paper
• Human cytomegalovirus and Herpes Simplex type I virus can engage RNA polymerase I for transcription of immediate early genes

  2017influential citation
• Advanced pancreatic ductal adenocarcinoma - Complexities of treatment and emerging therapeutic options

  2017cites this paper
• Étude structurale et fonctionnelle du complexe Rpf2/Rrs1 impliqué dans la biogenèse du ribosome

  2017cites this paper